Krystal Biotech (KRYS) Other Operating Expenses (2023 - 2025)
Historic Other Operating Expenses for Krystal Biotech (KRYS) over the last 3 years, with Q4 2025 value amounting to $6.6 million.
- Krystal Biotech's Other Operating Expenses rose 11757.87% to $6.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $23.0 million, marking a year-over-year increase of 17927.9%. This contributed to the annual value of -$37.5 million for FY2024, which is 13750.0% down from last year.
- Latest data reveals that Krystal Biotech reported Other Operating Expenses of $6.6 million as of Q4 2025, which was up 11757.87% from $4.3 million recorded in Q3 2025.
- Krystal Biotech's 5-year Other Operating Expenses high stood at $100.0 million for Q3 2023, and its period low was -$37.5 million during Q4 2024.
- In the last 3 years, Krystal Biotech's Other Operating Expenses had a median value of $5.5 million in 2024 and averaged $11.7 million.
- Over the last 5 years, Krystal Biotech's Other Operating Expenses had its largest YoY gain of 11757.87% in 2025, and its largest YoY loss of 1923.78% in 2025.
- Quarter analysis of 3 years shows Krystal Biotech's Other Operating Expenses stood at $100.0 million in 2023, then plummeted by 137.5% to -$37.5 million in 2024, then soared by 117.58% to $6.6 million in 2025.
- Its Other Operating Expenses was $6.6 million in Q4 2025, compared to $4.3 million in Q3 2025 and $7.2 million in Q2 2025.